Eravacycline is active against bacterial isolates expressing the polymyxin resistance gene mcr-1
- Fyfe, Corey Tetraphase Pharmaceuticals, Watertown, Massachusetts, USA
- LeBlanc, Gabrielle Tetraphase Pharmaceuticals, Watertown, Massachusetts, USA
- Close, Brianna Tetraphase Pharmaceuticals, Watertown, Massachusetts, USA
- Nordmann, Patrice Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Department of Medicine, INSERM European Unit, Paris, France - University of Fribourg, Switzerland - University of Lausanne, University Hospital Centre, Lausanne, Switzerland
- Dumas, Jacques Tetraphase Pharmaceuticals, Watertown, Massachusetts, USA
- Grossman, Trudy H. Tetraphase Pharmaceuticals, Watertown, Massachusetts, USA
-
11.01.2016
Published in:
- Antimicrobial Agents and Chemotherapy. - 2016, vol. 60, no. 11, p. 6989–6990
- Faculty
- Faculté des sciences et de médecine
- Department
- Médecine 3ème année
- Language
-
- English
- Classification
- Biological sciences
- License
- License undefined
- Identifiers
-
- RERO DOC 278646
- DOI 10.1128/AAC.01646-16
- Persistent URL
- https://folia.unifr.ch/unifr/documents/305468
Statistics
Document views: 13
File downloads:
- nor_eaa.pdf: 78